Cargando…

Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome

IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis worldwide. Due to its heterogenicity, there is a need to establish robust biomarkers for IgAN, to support treatment decisions and evaluate the risk of progression to end-stage renal disease. Using both clinical and histopathologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Konieczny, Andrzej, Donizy, Piotr, Gołębiowski, Tomasz, Tukiendorf, Andrzej, Hałoń, Agnieszka, Kusztal, Mariusz, Augustyniak-Bartosik, Hanna, Krajewska, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534654/
https://www.ncbi.nlm.nih.gov/pubmed/34679462
http://dx.doi.org/10.3390/diagnostics11101764
_version_ 1784587603605979136
author Konieczny, Andrzej
Donizy, Piotr
Gołębiowski, Tomasz
Tukiendorf, Andrzej
Hałoń, Agnieszka
Kusztal, Mariusz
Augustyniak-Bartosik, Hanna
Krajewska, Magdalena
author_facet Konieczny, Andrzej
Donizy, Piotr
Gołębiowski, Tomasz
Tukiendorf, Andrzej
Hałoń, Agnieszka
Kusztal, Mariusz
Augustyniak-Bartosik, Hanna
Krajewska, Magdalena
author_sort Konieczny, Andrzej
collection PubMed
description IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis worldwide. Due to its heterogenicity, there is a need to establish robust biomarkers for IgAN, to support treatment decisions and evaluate the risk of progression to end-stage renal disease. Using both clinical and histopathological data, derived from renal biopsies, we aimed to find predictors of renal function deterioration and proteinuria reduction. Clinical and histopathological data of 80 patients with biopsy proven IgAN were analyzed. In a multivariate logarithmic regression model, the presence of endocapillary hypercellularity (E1) predicted a decline in estimated glomerular filtration rate (eGFR)of at least 50% with an odds ratio (OR) of 15.2, whereas serum albumin concentration had a negative influence on eGFR deterioration (OR 0.2). In the second multivariate model, the extent of interstitial fibrosis predicted the worsening of eGFR by 50% (OR 1.1) and serum albumin concentration had a protective impact (OR 0.1). In the univariate logarithmic regression, both the extent of interstitial fibrosis and the presence of endocapillary hypercellularity negatively correlated with the reduction in proteinuria below 1.0 g/24 h with an OR of 0.2 and 0.9, respectively. In our paper, we confirmed the utility of histopathological variables, especially endocapillary hypercellularity and interstitial fibrosis, and clinical parameters, particularly serum albumin concentration, in the prediction of both a decline in eGFR and a reduction in proteinuria in IgA nephropathy.
format Online
Article
Text
id pubmed-8534654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85346542021-10-23 Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome Konieczny, Andrzej Donizy, Piotr Gołębiowski, Tomasz Tukiendorf, Andrzej Hałoń, Agnieszka Kusztal, Mariusz Augustyniak-Bartosik, Hanna Krajewska, Magdalena Diagnostics (Basel) Article IgA nephropathy (IgAN) is the most frequent primary glomerulonephritis worldwide. Due to its heterogenicity, there is a need to establish robust biomarkers for IgAN, to support treatment decisions and evaluate the risk of progression to end-stage renal disease. Using both clinical and histopathological data, derived from renal biopsies, we aimed to find predictors of renal function deterioration and proteinuria reduction. Clinical and histopathological data of 80 patients with biopsy proven IgAN were analyzed. In a multivariate logarithmic regression model, the presence of endocapillary hypercellularity (E1) predicted a decline in estimated glomerular filtration rate (eGFR)of at least 50% with an odds ratio (OR) of 15.2, whereas serum albumin concentration had a negative influence on eGFR deterioration (OR 0.2). In the second multivariate model, the extent of interstitial fibrosis predicted the worsening of eGFR by 50% (OR 1.1) and serum albumin concentration had a protective impact (OR 0.1). In the univariate logarithmic regression, both the extent of interstitial fibrosis and the presence of endocapillary hypercellularity negatively correlated with the reduction in proteinuria below 1.0 g/24 h with an OR of 0.2 and 0.9, respectively. In our paper, we confirmed the utility of histopathological variables, especially endocapillary hypercellularity and interstitial fibrosis, and clinical parameters, particularly serum albumin concentration, in the prediction of both a decline in eGFR and a reduction in proteinuria in IgA nephropathy. MDPI 2021-09-25 /pmc/articles/PMC8534654/ /pubmed/34679462 http://dx.doi.org/10.3390/diagnostics11101764 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Konieczny, Andrzej
Donizy, Piotr
Gołębiowski, Tomasz
Tukiendorf, Andrzej
Hałoń, Agnieszka
Kusztal, Mariusz
Augustyniak-Bartosik, Hanna
Krajewska, Magdalena
Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title_full Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title_fullStr Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title_full_unstemmed Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title_short Clinical and Histopathological Factors Influencing IgA Nephropathy Outcome
title_sort clinical and histopathological factors influencing iga nephropathy outcome
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534654/
https://www.ncbi.nlm.nih.gov/pubmed/34679462
http://dx.doi.org/10.3390/diagnostics11101764
work_keys_str_mv AT koniecznyandrzej clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT donizypiotr clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT gołebiowskitomasz clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT tukiendorfandrzej clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT hałonagnieszka clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT kusztalmariusz clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT augustyniakbartosikhanna clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome
AT krajewskamagdalena clinicalandhistopathologicalfactorsinfluencingiganephropathyoutcome